Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-β-lactamase–Producing Escherichia coli Causing Fatal Bloodstream Infection

Fiona Senchyna,Kanagavel Murugesan,William Rotunno,Sruti S Nadimpalli,Stan Deresinski,Niaz Banaei

DOI: https://doi.org/10.1093/cid/ciad759

IF: 20.999

2024-01-31

Clinical Infectious Diseases

Abstract:We report a fatal case of New Delhi metallo-β-lactamase (NDM)–producing Escherichia coli in a bacteremic patient with sequential failure of aztreonam plus ceftazidime-avibactam followed by cefiderocol. Acquired resistance was documented phenotypically and mediated through preexisting and acquired mutations. This case highlights the need to rethink optimal treatment for NDM-producing organisms.

immunology,infectious diseases,microbiology